MedPath

ITB-MED LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:6
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:7

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 2
7 (87.5%)
Phase 1
1 (12.5%)

A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients

Phase 1
Active, not recruiting
Conditions
ALS
First Posted Date
2024-06-12
Last Posted Date
2024-08-12
Lead Sponsor
ITB-Med LLC
Target Recruit Count
48
Registration Number
NCT06453668
Locations
🇸🇪

Skåne University Hospital Malmö, Malmö, Sweden

🇸🇪

Studieenheten Akademiskt Specialistcentrum, Stockholm, Sweden

🇸🇪

Umeå University Hospital, Umeå, Sweden

A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation

Phase 2
Completed
Conditions
Kidney Transplantation
Interventions
First Posted Date
2024-04-15
Last Posted Date
2025-01-29
Lead Sponsor
ITB-Med LLC
Target Recruit Count
33
Registration Number
NCT06365437
Locations
🇦🇹

Innsbruck Medical University, Innsbruck, Austria

🇦🇹

University of Vienna, Vienna, Austria

🇪🇸

Hospital Clinic de Barcelona, Barcelona, Spain

and more 4 locations

A Study of TCD601 (siplizumab) in New Onset Type 1 Diabetes Patients

Phase 2
Active, not recruiting
Conditions
Diabetes Mellitus, Type 1
Interventions
Other: Placebo
First Posted Date
2023-09-06
Last Posted Date
2025-03-05
Lead Sponsor
ITB-Med LLC
Target Recruit Count
96
Registration Number
NCT06025110
Locations
🇧🇪

UZ Brussel, Brussel, Belgium

🇧🇪

UZ Leuven, Leuven, Belgium

🇮🇹

Azienda Ospedaliero-Universitaria Renato Dulbecco, Catanzaro, Italy

and more 23 locations

A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation

Phase 2
Active, not recruiting
Conditions
Liver Transplantation
Interventions
First Posted Date
2023-08-31
Last Posted Date
2024-11-27
Lead Sponsor
ITB-Med LLC
Target Recruit Count
12
Registration Number
NCT06019507
Locations
🇸🇪

Karolinska University Hospital, Stockholm, Huddinge, Sweden

A Study of TCD601 in de Novo Renal Transplant Recipients

Phase 2
Active, not recruiting
Conditions
Renal Transplantation
Interventions
First Posted Date
2022-12-30
Last Posted Date
2025-04-17
Lead Sponsor
ITB-Med LLC
Target Recruit Count
90
Registration Number
NCT05669001
Locations
🇺🇸

Scripps Green Hospital, La Jolla, California, United States

🇺🇸

University of Southern California, Los Angeles, California, United States

🇺🇸

University of California Davis Medical Center, Sacramento, California, United States

and more 24 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.